Spin-out unites three sites to create a leading global CDMO as further significant investments announced at Holmes Chapel site Holmes Chapel, UK, and Stockholm, Sweden; Tuesday 2 nd April 2024 ...

Bespak by Recipharm delivers market leading design, development, and manufacture of drug delivery devices to the global pharmaceutical market. Bespak by Recipharm delivers market leading design, ...

Holmes Chapel, UK, and Chippenham, UK, 10 th December 2024 — Bespak, a specialist inhalation contract development and manufacturing organisation (CDMO), and OzUK, an independent contract research ...

Bespak, a leading CDMO focused on orally inhaled and nasal drug-device combination products, announced the progress in its commitment to the production of low global warming potential (GWP) ...

Novel business model set to streamline and speed products to market whilst reducing cost and complexity of development 11 November 2015:- Bespak, a world leading drug delivery device design, ...

Consort Medical has combined and integrated Aesica’s drug formulation, manufacturing, and packaging capabilities with Bespak’s drug-delivery device design, development, and manufacturing services to ...

Bespak has announced the launch of Syrina™ 2.25 at PDA Europe 2015. Moreover, Steven Kaufman, Global Business Development Lead at the company, will chair a 1-day specialized industry discussion on ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Bespak confirms completion of inhaled and nasal drug delivery business separation from Recipharm. Historically, Bespak is the name used by its King's Lynn, UK site - a leading global supplier of ...

Bespak has announced the launch of the Syrina™ AR 2.25 auto-injector. This innovative auto-injector is the latest addition to the VapourSoft™ -powered Syrina range and is suitable for delivering ...